Next, to evaluate directly whether the activation of IDO in the PrL and IL is responsible for depression-like behavior in ICV-STZ rats, we subsequently inhibited IDO by microinjecting 1-MT in the PrL or IL and observed its effects on the behaviors of ICV-STZ rats. Here, IDO1 is linked to depressive symptom measurement.